Tandem Diabetes Care, Inc. (TNDM) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

TransMedics Group, Inc.

AtriCure, Inc.

PROCEPT BioRobotics Corp.

Veracyte, Inc.

Integer Holdings Corp.

NovoCure Ltd.

Tandem Diabetes Care, Inc.

Alphatec Holdings, Inc.

InMode Ltd.

Pacific Biosciences of California, Inc.

STAAR Surgical Co.

Why is Tandem Diabetes Care, Inc. ?

Poor Management Efficiency with a low ROE of 0.30%

The company has been able to generate a Return on Equity (avg) of 0.30% signifying low profitability per unit of shareholders funds

Flat results in Jun 25

ROCE(HY) Lowest at -111.91%
DEBT-EQUITY RATIO (HY) Highest at 100.27 %
INTEREST(Q) Highest at USD 2.54 MM

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -28.21%, its profits have risen by 22.5%

High Institutional Holdings at 100%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Underperformed the market in the last 1 year

Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -28.21% returns

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Tandem Diabetes Care, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tandem Diabetes Care, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Tandem Diabetes Care, Inc.

-37.94%

-0.73

75.30%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

19.55%

EBIT Growth (5y)

-208.96%

EBIT to Interest (avg)

-9.31

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

1.45

Tax Ratio

5.41%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

2.83%

ROE (avg)

0.30%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

8.91

EV to EBIT

-13.44

EV to EBITDA

-16.07

EV to Capital Employed

8.84

EV to Sales

1.41

PEG Ratio

Dividend Yield

ROCE (Latest)

-65.75%

ROE (Latest)

-69.96%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 9.72 MM

NET PROFIT(HY)

Higher at USD -87.79 MM

RAW MATERIAL COST(Y)

Fallen by -2.93% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 8.84 times

-8What is not working for the Company

ROCE(HY)

Lowest at -111.91%

DEBT-EQUITY RATIO (HY)

Highest at 100.27 %

INTEREST(Q)

Highest at USD 2.54 MM

PRE-TAX PROFIT(Q)

Fallen at -26.99%

Here's what is working for Tandem Diabetes Care, Inc.

Net Profit

Higher at USD -87.79 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Operating Cash Flow

Highest at USD 9.72 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debtors Turnover Ratio

Highest at 8.84 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -2.93% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at USD 4.37 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Tandem Diabetes Care, Inc.

Interest

At USD 2.54 MM has Grown at 36.25%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio

Highest at 100.27 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at USD 2.54 MM

in the last five periods and Increased by 36.25% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Pre-Tax Profit

Fallen at -26.99%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)